Showing results (61-70 of 3,346) with videos related to
Sort By:
Pageof 335
Pharmacoeconomics|July 18, 2023
Cost-Effectiveness of Hydroxyurea for Sickle Cell Anemia in a Low-Income African Setting: A Model-Based Evaluation of Two Dosing RegimensDavid Teigen, Robert O Opoka, Phillip Kasirye, et al.Pharmacoeconomics|June 23, 2023
Health Economic Evidence and Modeling Challenges for Liquid Biopsy Assays in Cancer Management: A Systematic Literature ReviewMussab Fagery, Hadi A Khorshidi, Stephen Q Wong, et al.Pharmacoeconomics|January 8, 2003
Economic implications of the use of basiliximab in addition to triple immunosuppressive therapy in renal allograft recipients: a UK perspectiveStephen J Walters, Malcolm Whitfield, Ronald L Akehurst, et al.Pharmacoeconomics|March 12, 2003
A simulation model for estimating direct costs of type 1 diabetes preventionJarmo Hahl, Tuula Simell, Antti Kupila, et al.Pharmacoeconomics|March 12, 2003
The cost effectiveness of two new antiepileptic therapies in the absence of direct comparative data: a first approximationBen A van Hout, Dennis D Gagnon, Pauline McNulty, et al.Pharmacoeconomics|March 22, 2003
The economic burden of stroke in the United KingdomPenny Youman, Koo Wilson, Farzaneh Harraf, et al.Pharmacoeconomics|October 17, 2002
The annual societal cost of alcohol misuse in ScotlandSusan J Varney, Julian F GuestPharmacoeconomics|November 29, 2002
Health state preference assessment in diabetic peripheral neuropathySean D Sullivan, Doris P Lew, E Beth Devine, et al.Pharmacoeconomics|October 31, 2002
Pharmacoeconomic considerations in assessing and selecting congestive heart failure therapiesEmile Levy, Pierre LevyPharmacoeconomics|November 30, 2002
The prospects for reform of the Japanese healthcare systemTadahiko TokitaPageof 335